A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.

The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after ...

Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...

Results suggest potential effectiveness in settings such as nursing homes ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

A hantavirus outbreak aboard a luxury cruise ship that has left three people dead is veering into the fringe. Online, a ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

KANSAS CITY, Mo. — A University Health occupational therapist says communities like Kansas City need to keep talking about long COVID. “We need to continue this conversation about long COVID, even if ...

In a visually striking medical case, a baby's eyes changed color while he was receiving care in a hospital.

Moore Vogel is a long Covid patient-researcher at Scripps Research and the Patient Led Research Collaborative (PLRC). Charlie McCone is a long Covid patient advocate, is a member of the PLRC, and has ...

While adults have dominated long COVID headlines, a growing body of research is revealing that teenagers are experiencing persistent lung damage that’s fundamentally different from what we see in ...